|
124I-cG250 ImmunoPET Imaging of Sunitinib Treatment Response in Renal Cell Cancer
|
1R21CA162602-01A1
|
$375,713
|
Larson, Steven
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$300,744
|
Barchi, Joseph
|
CCR (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,178,242
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-35
|
$7,696,742
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-35S1
|
$50,000
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-04S1
|
$200,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-04S2
|
$450,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-04S3
|
$150,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
5U01CA121947-05
|
$5,189,968
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Analysis of Imprinting Control of the Beckwith Wiedeman Domain
|
5K22CA140361-03
|
$168,380
|
ENGEL, NORA
|
TEMPLE UNIVERSITY
|
|
Analysis of the VHL-HIF hydroxylase pathway
|
5R01CA125020-05
|
$215,262
|
SHIIO, YUZURU
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,179,485
|
Oberholtzer, J.
|
CCR (NCI)
|
|
Arginase Production in Cancer: Evading Immune Response
|
2R01CA107974-06A1
|
$279,922
|
OCHOA, AUGUSTO
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
ATBC Study
|
ZIA CP010195-03031
|
$828,679
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Atlanta Regional Community Clinical Oncology Program (ARCCOP)
|
5U10CA045450-25
|
$482,599
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
B7-H1/PD-1 modulation in cancer therapy
|
5R01CA142779-02
|
$479,334
|
PARDOLL, DREW
|
JOHNS HOPKINS UNIVERSITY
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-22
|
$406,165
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-10S1
|
$140,000
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-10
|
$882,302
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$891,092
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Botulinum Toxin for Painful Cutaneous Leiomyomas
|
ZIA BC 011177
|
$24,991
|
Kong, Heidi
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,020,703
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Cadherin-regulated apoptosis and survival signaling in epithelial cells
|
1R01CA142647-01A1
|
$358,629
|
HANSEN, STEEN
|
CHILDREN'S HOSPITAL BOSTON
|
|
CALGB Member Site: University of California - San Francisco
|
5U10CA138561-03
|
$103,395
|
Ryan, Charles
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIA BC 011300
|
$641,770
|
Dean, Michael
|
CCR (NCI)
|
|
Cancer and Leukemia Group B
|
3U10CA031946-30S1
|
$3,449,605
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-30
|
$10,820,362
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA032291-30
|
$469,660
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer and Leukemia Group B
|
5U10CA047577-24
|
$95,798
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA077597-14
|
$87,915
|
Liu, Minetta
|
GEORGETOWN UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA077651-14
|
$201,215
|
Hudis, Clifford
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer and Leukemia Group B
|
5U10CA041287-26
|
$244,995
|
KINDLER, HEDY
|
UNIVERSITY OF CHICAGO
|
|
Cancer and Leukemia Group B
|
5U10CA047559-21
|
$119,336
|
SHEA, THOMAS
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer and Leukemia Group B - Leukemia Correlative Sciences
|
5U10CA101140-09
|
$783,858
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-14
|
$462,357
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-27
|
$2,389,751
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B Statistical Center
|
5U10CA033601-33
|
$4,682,808
|
SARGENT, DANIEL
|
MAYO CLINIC
|
|
Cancer and Leukemia Group B: RPCI/SUNYAB
|
5U10CA059518-19
|
$181,261
|
LEVINE, ELLIS
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Cancer Center Core Support Grant
|
2P30CA016086-35
|
$6,839,993
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-35S1
|
$250,000
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-35S2
|
$74,653
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S5
|
$11,164,583
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S6
|
$75,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA008748-46S1
|
$249,999
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer Center Support Grant
|
3P30CA008748-46S2
|
$50,000
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer Center Support Grant
|
3P30CA008748-46S3
|
$75,000
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer Center Support Grant
|
5P30CA008748-46
|
$13,185,550
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer Center Support Grant
|
3P30CA082103-13S1
|
$112,399
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-13S2
|
$249,998
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-13S3
|
$249,998
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|